Skip to main content
Epilepsia Open logoLink to Epilepsia Open
. 2022 Apr 19;7(2):325–331. doi: 10.1002/epi4.12600

The effects of COVID‐19 measures on the hospitalization of patients with epilepsy and status epilepticus in Thailand: An interrupted time series analysis

Prapassara Sirikarn 1,2, Siriporn Tiamkao 2,3, Somsak Tiamkao 2,4,
PMCID: PMC9110909  PMID: 35403839

Abstract

Objective

To investigate the effect of Coronavirus disease 2019 (COVID‐19) measures on the hospitalization of patients with epilepsy and status epilepticus (SE).

Methods

This interrupted time series design included data from the Thai Universal Coverage Scheme electronic database between January 2017 and September 2020. The monthly hospitalization rate of epilepsy and SE was calculated by the number of hospitalizations divided by the midyear population. Segmented regression fitted by ordinary least squares (OLS) was used to detect the immediate and overtime effects of COVID‐19 measures on the hospitalization rate.

Results

During January 2017 and September 2020, the numbers of epilepsy and SE patients admitted to the hospital were 129 402 and 15 547 episodes, respectively. The monthly trend of the hospitalization rate in epilepsy decreased immediately after the COVID‐19 measure (0.739 per 100 000 population [95% CI: 0.219 to 1.260]). In particular, the number of children declined to 1.178 per 100 000 population, and the number of elderly individuals dropped to 0.467 per 100 000 population, while there was a nonstatistically significant change in SE.

Significance

COVID‐19 measures reduced the hospital rate in epilepsy, particularly in children and adults. However, there was no change in SE patients.

Keywords: coronavirus disease, hospital admission, noncommunicable diseases, public measures, seizure


Key points.

  • The COVID‐19 measures impacted the hospitalization rate differently in each age group.

  • The hospitalization of epilepsy decreased after COVID‐19 measure implementation in children and elderly

  • There was a nonstatistically significant change of hospitalization rate after COVID‐19 measure implementation in SE

1. INTRODUCTION

Coronavirus disease 2019 (COVID‐19) is an emergency respiratory infection that rapidly spreads from person to person and becomes pandemic in a short time. 1 The continuously increasing number of COVID‐19 cases impacts the system of public health, economy, or education worldwide. Various public health measures have been implemented to limit the spread of disease (e.g., lockdown, social distancing, or wearing a face mask). 2 , 3 , 4

Thailand first reported the COVID‐19 cases in January 2020. Since the first COVID‐19 cases were found, the newly cases gradually increased until early March, the number of cases rapidly rose because of the local transmission cluster in Bangkok that mostly tract to boxing stadium and nightclubs. Thus, the public places were closed (e.g., mall, market, and school), and the partial lockdown was implemented in and outside Bangkok. However, the cases spread widely throughout the country within March due to the workers in Bangkok returned to their hometowns. Then, a curfew, restriction of movement, and active case finding were implemented in April across the country. 5 , 6

The measures not only slowed down COVID‐19 cases 7 , 8 , 9 but also affected the number of other public health issues, such as drug overdose, 10 , 11 , 12 accidents, 13 , 14 respiratory diseases, 15 , 16 , 17 respiratory tract infection, 18 , 19 and mental health. 20 , 21 Moreover, as a consequence of the growing number of COVID‐19 cases and established measures, health care resources have been conserved for COVID‐19 patients. Thus, hospitals have restricted or delayed treatment for nonessential cases, causing the hospitalization of inpatients with noncommunicable diseases to decrease. 22 , 23 , 24

Epilepsy and status epilepticus (SE) are neurological disorders that affect disability and mortality. The discontinuation of antiseizures medications in epilepsy patients is a common etiology of SE; continuous therapy is required to reduce the frequency and severity of the seizure. 25 Given the consequences of the COVID‐19 outbreak and implemented measures, patients ranging from 4% to 35% had worse seizure control because of sleep problems, depression, and anxiety factors. In addition, 14.5% to 61.0% of those were postponed neurological tests. 26 Previous studies have shown that COVID‐19 decreased the number of seizure‐related admissions in children, 27 while there was no change in adult SE patients. 28 However, previous reports have studied children and adults. Therefore, this study aimed to investigate the effect of COVID‐19 measures on the hospitalization of all patients with epilepsy and SE.

2. MATERIALS AND METHODS

2.1. Design and setting

This study was an interrupted time series (ITS) design and conducted the data on the Thai Universal Coverage Scheme electronic database, which is an insurance of Thai citizens and covers over 75% of the Thai population.

2.2. Participants

Patients who were admitted to the hospital and had a primary diagnosis of epilepsy and SE from January 2017 to September 2020 were included. The database search was performed by using guidelines described in the International Statistical Classification of Diseases and Related Health Problems – 10th Revision (ICD‐10) with codes G40 (epilepsy) and G41 (SE). Epilepsy and SE diagnosis were followed by the guideline of the International League Against Epilepsy. 29 , 30 There were no restrictions on age, sex, or epilepsy and SE type. Patients with missing date of admission were also excluded.

2.3. The COVID‐19 transmission and public health measures in Thailand

The COVID‐19 outbreak in Thailand began in January 2020 and the number of newly cases peaked in March which were mainly cause form local transmission cluster in Bangkok. Thus, the state of emergency announced on 26 March to impose the partial lockdown which was a nighttime curfew and a ban on gatherings of more than five people in and around Bangkok. As a result of state of emergency announcement, the public venues were closed and working from home was encouraged. However, the cases continuously rose and widely spread throughout the country because the workers migrated to countryside. Then, a nationwide curfew was implemented on April 3, 2020. In addition, restriction of movement, and active case finding were established in several provinces. 5

2.4. Outcome

The monthly hospitalization rate of epilepsy and SE was calculated by the number of hospitalizations divided by the midyear population.

2.5. Sample size

We used the monthly hospitalization rate during January 2017 to September 2020 to perform an ITS analysis for evaluating the impact of COVID‐19 measures. Thus, there were 36‐time points before and nine points after established measures which had an adequate sample size for ITS analysis. 31

2.6. Statistical analysis

Segmented regression fitted by ordinary least squares (OLS) was used to detect the immediate and overtime effect of COVID‐19 measures in April 2020 (curfew, movement restriction, and active case finding) on the hospitalization rate. The equation of segmented regression model was represented as follows:

Yt=β0+β1×timet+β2×interventiont+β3×timeafter interventiont+et

When Ytis the hospitalization rate at time t, time indicate time in month from the start (January 2017) to end (September 2020) of the observation, intervention is the indicator for time t occurring before (intervention = 0) or after (intervention = 1) the implementation of the COVID‐19 measures, β0estimate the baseline level of hospitalization rate at t0, β1represent hospitalization trend before introducing the COVID‐19 measures, β2is the level change of hospitalization rate immediately after measures implementation, β3show the trend change between before and after establishing the COVID‐19 measures, and β1+β3estimate the trend of post‐intervention. Autocorrelation was examined by the Cumby–Huizinga test, and the Newey–West standard error was used to account for autocorrelation. The seasonal effect was controlled by including it as a covariate in the model. 32 , 33 All statistical analyses were performed by STATA 15.0. The study protocol was approved by the ethics committee in human research, Khon Kaen University, Khon Kaen, Thailand (HE641589).

3. RESULTS

During January 2017 and September 2020, the numbers of epilepsy and SE patients admitted to the hospital were 129 402 and 15 547 episodes, respectively. Most of the patients were men, and the median age was 36 (interquartile range [IQR] = 35) for epilepsy and 42 (IQR = 45) for SE patients (Table 1). The hospitalization rate of epilepsy before the COVID‐19 spread peaked in the early year and fluctuated over the year, the rate in 2020 presented dramatically dropped from January to April. While SE was high at early of the year and gradually decreased until it returned to high again in the midyear (Figure 1). Thus, the effect of seasonality was controlled to consider the effect of COVID‐19 measures on the hospitalization of epilepsy and SE.

TABLE 1.

Characteristics of admitted epilepsy and SE patients

Characteristics Epilepsy (n = 129 402) SE (n = 15 547)
n (%) n (%)
Sex
Male 83 831 (64.8) 9815 (63.1)
Female 45 571 (35.2) 5732 (36.9)
Age (years)
<10 20 453 (15.8) 3249 (20.9)
10–19 15 822 (12.2) 1159 (7.4)
20–29 17 379 (13.4) 1355 (8.7)
30–39 18 423 (14.2) 1598 (10.3)
40–49 20 476 (15.8) 2048 (13.2)
50–59 16 398 (12.7) 2092 (13.5)
≥60 20 451 (15.8) 4046 (26.0)
Mean (SD) 35.60 (22.2) 39.3 (26.0)
Median (IQR) 36 (35) 42 (45)
Season a
Summer 42 700 (33.0) 5133 (33.0)
Rainy 47 103 (36.4) 5685 (36.6)
Winter 39 599 (30.6) 4729 (30.4)

Abbreviations: IQR, interquartile range; SD, standard deviation; SE, status epilepticus.

Season including summer (February to May), rainy (June to September), and winter (October to January).

FIGURE 1.

FIGURE 1

The hospitalization rate of epilepsy (A) and SE (B) patients during 2017 and 2020. SE, status epilepticus

3.1. Hospitalization rate for epilepsy

The trend of hospitalization rate for overall epilepsy before the implementation of the measures increased 0.010 per 100 000 population in each month and it dropped to 0.739 per 100 000 population immediately after the first month of the COVID‐19 measure was implemented. In particular, the hospitalization rate in elderly individuals declined to 0.467 per 100 000 population, and that in children declined to 1.178 per 100 000 population. However, the monthly trend after measures increased in children (Table 2).

TABLE 2.

Effect of COVID‐19 measures on the hospitalization rate in epilepsy and SE patients

Preintervention trend: β1 Immediate level change: β2 Trend change: β3 Post‐intervention trend: β1+β3

Hospitalization rate

(95% CI)

P‐value

Hospitalization rate

(95% CI)

P‐value

Hospitalization rate

(95% CI)

P‐value

Hospitalization rate

(95% CI)

P‐value
Epilepsy
Overall

0.010

(0.003 to 0.162)

.005

−0.739

(−1.260 to −0.219)

.007

0.112

(−0.073 to 0.298)

.228

0.122

(−0.062 to 0.306)

.188
Childrena

0.015

(0.006 to 0.023)

.001

−1.178

(−1.478 to −0.879)

<.001

0.129

(0.020 to 0.239)

.022

0.144

(0.036 to 0.252)

.010
Adultb

0.008

(0.002 to 0.014)

.015

−0.603

(−1.342 to 0.136)

.107

0.125

(−0.115 to 0.366)

.297

0.133

(−0.106 to 0.373)

.267
Elderly peoplec

0.012

(−0.003 to 0.028)

.107

−0.467

(−0.908 to −0.025)

.039

0.122

(−0.079 to 0.323)

.288

0.134

(−0.071 to 0.339)

.193
SE
Overall

−0.001

(−0.002 to 0.001)

.217

−0.039

(−0.113 to 0.036)

.298

0.001

(−0.023 to 0.024)

.947

0.0001

(−0.024 to 0.024)

.992
Childrena

−0.002

(−0.004 to 0.001)

.136

−0.089

(−0.218 to 0.040)

.170

−0.030

(−0.075 to 0.016)

.193

−0.032

(−0.077 to 0.014)

.171
Adultb

−0.0002

(−0.002 to 0.001)

.794

−0.033

(−0.086 to 0.020)

.212

0.007

(−0.010 to 0.023)

.421

0.006

(−0.010 to 0.022)

.428
Elderly peoplec

−0.002

(−0.005 to 0.001)

.203

0.006

(−0.134 to 0.145)

.934

0.023

(−0.013 to 0.059)

.200

0.021

(−0.014 to 0.057)

.230

Abbreviation: SE, status epilepticus.

Children, less than 20 years old.

Adult, 20 to 59 years old.

Elderly people, 60 years old and above.

3.2. Hospitalization rate for SE

The immediate and overtime effects of measures on the hospitalization rate of SE were not statistically significant for all age groups (Table 2).

4. DISCUSSION

The first COVID‐19 case in Thailand was reported in January 2020, and the number of cases rose continually. Thus, the curfew, movement restriction, and active case finding measures were established in April 2020 to control the spread of COVID‐19. These measures affected the reduction in hospitalization of epilepsy in pediatric (0.129 per 100 000 population), which was similar to previous studies that reported a 59% decrease. 27 Moreover, our findings found that the hospitalization in the elderly also declined after the first month of measures (0.467 per 100 000 population). Due to concern about COVID‐19 infection, medical appointments were canceled or postponed, 34 and the results found that increasing age was an important factor associated with experiencing a delay. 35 In particular, worry in caregivers or parents was a reason for delayed hospitalization in children. 36 Furthermore, the measures (e.g., lockdown and social isolation) were another cause for canceling appointments scheduled at medical care. 37 , 38 Although the hospitalization rate of epilepsy in pediatric and elderly after the first month of implemented measures decreased, the overall trend after measures increased in pediatric patients because of therapy discontinuation in the early COVID‐19 period and measure implementation.

In contrast to epilepsy, our SE results showed there was no change in the immediate and overtime effects of COVID‐19 measures on the hospitalization rate, which was consistent with the latest study. 28 Because seizures are more severe in SE patients, patients require rapid treatment. Thus, the hospitalization rate of SE was not different between before and after establishing COVID‐19 measures.

In addition, our study showed that the seasonal pattern increased the hospitalization of epilepsy (rainy: 0.379 per 100 000 population [95% CI: 0.200 to 0.558] and winter: 0.491 per 100 000 population [95% CI: 0.308 to 0.674]) and SE (rainy: 0.060 per 100 000 population [95% CI: 0.034 to 0.085] and winter: 0.061 per 100 000 population [95% CI: 0.035 to 0.087]), which was in accordance with previous research reporting that seasonality affected the number of epileptic seizures. 39 , 40 , 41 Preferably in a country with a generally hot temperature, the turning from hot to cold weather is one of the triggers to increase the risk of seizures.

To our knowledge, this study reported the effect of COVID‐19 measures on the hospitalization rate of epilepsy and SE and conducted data with a large sample size based on multicentre data collection. Additionally, we performed subgroup analysis by age, which was classified into children, adults, and elderly. These results provided information to plan for preventing the hospitalization of a specific age group, for instance, the physicians need to provide the information on continued medication intake to caregivers of pediatric and elderly patients in the outbreak situation because discontinuation of antiseizures medications leads to worse seizure control and eventually hospital admission. However, this study examined the effect of COVID‐19 measures only in the first wave in Thailand because the time duration and measures in the first wave could obviously identify. Furthermore, living in different COVID‐19 zoning areas, especially the red zone that is the area with the continued surge in cases and the maximum control, can impact decisions to go to the hospital. Moreover, the database did not contain information about antiseizure medications which are the important factor associated with hospital admission in epilepsy and SE. Thus, further studies are needed to evaluate the effect of COVID‐19 measures on the hospitalization rate of epilepsy and SE in various COVID‐19 zoning areas and performing subgroup analysis in with and without continuous antiseizure medications.

In conclusion, the COVID‐19 measures impacted the reduced hospitalization rate in epilepsy, especially children and adults, but there was a nonsignificant decrease in SE patients.

CONFLICT OF INTEREST

None of the authors has any conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Sirikarn P, Tiamkao S, Tiamkao S. The effects of COVID‐19 measures on the hospitalization of patients with epilepsy and status epilepticus in Thailand: An interrupted time series analysis. Epilepsia Open. 2022;7:325–331. 10.1002/epi4.12600

REFERENCES

  • 1. Cucinotta D, Vanelli M. WHO declares COVID‐19 a pandemic. Acta Biomed. 2020;91:157–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Sen‐Crowe B, McKenney M, Elkbuli A. Social distancing during the COVID‐19 pandemic: staying home save lives. Am J Emerg Med. 2020;38:1519–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Wilder‐Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old‐style public health measures in the novel coronavirus (2019‐nCoV) outbreak. J Travel Med. 2020;27:taaa020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Leung CC, Cheng KK, Lam TH, Migliori GB. Mask wearing to complement social distancing and save lives during COVID‐19. Int J Tuberc Lung Dis. 2020;24:556–8. [DOI] [PubMed] [Google Scholar]
  • 5. Thailand WHO . Coronavirus disease 2019 (COVID‐19) WHO Thailand situation report – March 30, 2020; 2020.
  • 6. Oxford Policy Management, United Nations . Social impact assessment of COVID‐19 in Thailand. Oxford, UK: Oxford Policy Management Limited; 2020. [Google Scholar]
  • 7. Silva L, Figueiredo Filho D, Fernandes A. The effect of lockdown on the COVID‐19 epidemic in Brazil: evidence from an interrupted time series design. Cad Saude Publica. 2020;36:e00213920. [DOI] [PubMed] [Google Scholar]
  • 8. Islam N, Sharp SJ, Chowell G, Shabnam S, Kawachi I, Lacey B, et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ. 2020;370:m2743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Alimohamadi Y, Holakouie‐Naieni K, Sepandi M, Taghdir M. Effect of social distancing on COVID‐19 incidence and mortality in Iran since February 20 to may 13, 2020: an interrupted time series analysis. Risk Manag Healthc Policy. 2020;13:1695–700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID‐19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Glober N, Mohler G, Huynh P, Arkins T, O'Donnell D, Carter J, et al. Impact of COVID‐19 pandemic on drug overdoses in Indianapolis. J Urban Health. 2020;97:802–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Pines JM, Zocchi MS, Black BS, Carlson JN, Celedon P, Moghtaderi A, et al. How emergency department visits for substance use disorders have evolved during the early COVID‐19 pandemic. J Subst Abus Treat. 2021;129:108391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Mulholland RH, Wood R, Stagg HR, Fischbacher C, Villacampa J, Simpson CR, et al. Impact of COVID‐19 on accident and emergency attendances and emergency and planned hospital admissions in Scotland: an interrupted time‐series analysis. J R Soc Med. 2020;113:444–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Doucette ML, Tucker A, Auguste ME, Watkins A, Green C, Pereira FE, et al. Initial impact of COVID‐19's stay‐at‐home order on motor vehicle traffic and crash patterns in Connecticut: an interrupted time series analysis. Inj Prev. 2021;27:3–9. [DOI] [PubMed] [Google Scholar]
  • 15. Alsallakh MA, Sivakumaran S, Kennedy S, Vasileiou E, Lyons RA, Robertson C, et al. Impact of COVID‐19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Med. 2021;19:124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Davies GA, Alsallakh MA, Sivakumaran S, Vasileiou E, Lyons RA, Robertson C, et al. Impact of COVID‐19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax. 2021;76:867–73. [DOI] [PubMed] [Google Scholar]
  • 17. Shah SA, Quint JK, Nwaru BI, Sheikh A. Impact of COVID‐19 national lockdown on asthma exacerbations: interrupted time‐series analysis of English primary care data. Thorax. 2021;76:860–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Kishimoto K, Bun S, Shin J, Takada D, Morishita T, Kunisawa S, et al. Early impact of school closure and social distancing for COVID‐19 on the number of inpatients with childhood non‐COVID‐19 acute infections in Japan. Eur J Pediatr. 2021;180:2871–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Todd IMF, Miller JE, Rowe SL, Burgner DP, Sullivan SG. Changes in infection‐related hospitalizations in children following pandemic restrictions: an interrupted time‐series analysis of total population data. Int J Epidemiol. 2021;50:1435–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Mansfield KE, Mathur R, Tazare J, Henderson AD, Mulick AR, Carreira H, et al. Indirect acute effects of the COVID‐19 pandemic on physical and mental health in the UK: a population‐based study. Lancet Digit Health. 2021;3:e217–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Mukadam N, Sommerlad A, Wright J, Smith A, Szczap A, Solomou S, et al. Acute mental health presentations before and during the COVID‐19 pandemic. BJPsych Open. 2021;7:e134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Abebe W, Worku A, Moges T, Tekle N, Amogne W, Haile T, et al. Trends of follow‐up clinic visits and admissions three‐months before and during COVID‐19 pandemic at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia: an interrupted time series analysis. BMC Health Serv Res. 2021;21:731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Doubova SV, Leslie HH, Kruk ME, Pérez‐Cuevas R, Arsenault C. Disruption in essential health services in Mexico during COVID‐19: an interrupted time series analysis of health information system data. BMJ Glob Heal. 2021;6:e006204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hategeka C, Carter SE, Chenge FM, Katanga EN, Lurton G, Mayaka SM‐N, et al. Impact of the COVID‐19 pandemic and response on the utilisation of health services in public facilities during the first wave in Kinshasa, The Democratic Republic of the Congo. BMJ Glob Heal. 2021;6:e005955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Valton L, Benaiteau M, Denuelle M, Rulquin F, Hachon Le Camus C, Hein C, et al. Etiological assessment of status epilepticus. Rev Neurol. 2020;176:408–26. [DOI] [PubMed] [Google Scholar]
  • 26. Mostacci B, Licchetta L, Cacciavillani C, Di Vito L, Ferri L, Menghi V, et al. The impact of the COVID‐19 pandemic on people with epilepsy. An Italian survey and a global perspective. Front Neurol. 2020;11:613719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Davico C, Marcotulli D, Lux C, Calderoni D, Terrinoni A, Di Santo F, et al. Where have the children with epilepsy gone? An observational study of seizure‐related accesses to emergency department at the time of COVID‐19. Seizure. 2020;83:38–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Leitinger M, Poppert K, Mauritz M, Rossini F, Zimmermann G, Rohracher A, et al. Status epilepticus admissions during the COVID‐19 pandemic in Salzburg—a population‐based study. Epilepsia. 2020;61:e198–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475–82. [DOI] [PubMed] [Google Scholar]
  • 30. Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus – report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–23. [DOI] [PubMed] [Google Scholar]
  • 31. Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr. 2013;13:S38–44. [DOI] [PubMed] [Google Scholar]
  • 32. Linden A. Conducting interrupted time‐series analysis for single‐ and multiple‐group comparisons. Stata J Promot Commun Stat Stata. 2015;15:480–500. [Google Scholar]
  • 33. Wagner AK, Soumerai SB, Zhang F, Ross‐Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299–309. [DOI] [PubMed] [Google Scholar]
  • 34. Assenza G, Lanzone J, Brigo F, Coppola A, Di Gennaro G, Di Lazzaro V, et al. Epilepsy care in the time of COVID‐19 pandemic in Italy: risk factors for seizure worsening. Front Neurol. 2020;11:737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Papautsky EL, Rice DR, Ghoneima H, McKowen ALW, Anderson N, Wootton AR, et al. Characterizing health care delays and interruptions in the United States during the COVID‐19 pandemic: internet‐based, cross‐sectional survey study. J Med Internet Res. 2021;23:e25446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Davis AL, Sunderji A, Marneni SR, Seiler M, Hall JE, Cotanda CP, et al. Caregiver‐reported delay in presentation to pediatric emergency departments for fear of contracting COVID‐19: a multi‐national cross‐sectional study. Can J Emerg Med. 2021;23:778–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Sutter R, Kaplan PW, Rüegg S. Outcome predictors for status epilepticus‐‐what really counts. Nat Rev Neurol. 2013;9:525–34. [DOI] [PubMed] [Google Scholar]
  • 38. Rossetti AO, Logroscino G, Liaudet L, Ruffieux C, Ribordy V, Schaller MD, et al. Status epilepticus: an independent outcome predictor after cerebral anoxia. Neurology. 2007;69:255–60. [DOI] [PubMed] [Google Scholar]
  • 39. Alexandratou I, Verentzioti A, Siatouni A, Alexoudi A, Gkougka D, Alexandratou I, et al. Seasonal pattern of epileptic seizures: a single‐center experience. Neurol Neurobiol. 2020;3:2–4. [Google Scholar]
  • 40. Clemens Z, Holló A, Kelemen A, Rásonyi G, Fabó D, Halász P, et al. Seasonality in epileptic seizures. J Neurol Transl Neurosci. 2013;1:1016. [Google Scholar]
  • 41. Chiang K‐L, Lee J‐Y, Chang Y‐M, Kuo F‐C, Huang C‐Y. The effect of weather, air pollution and seasonality on the number of patient visits for epileptic seizures: a population‐based time‐series study. Epilepsy Behav. 2021;15:107487. [DOI] [PubMed] [Google Scholar]

Articles from Epilepsia Open are provided here courtesy of Wiley Periodicals Inc. on behalf of International League Against Epilepsy

RESOURCES